Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 74OTHER 71NIH 13OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 38Sarcoma 7CNS 6Endocrine 5Gynecologic 4Gastrointestinal 4Head & Neck 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 168Lung Neoplasms 148Adenocarcinoma of Lung 37Small Cell Lung Carcinoma 23Adenocarcinoma, Bronchiolo-Alveolar 20Breast Neoplasms 15Mesothelioma, Malignant 13Colorectal Neoplasms 11Colonic Neoplasms 10Prostatic Neoplasms 9Rectal Neoplasms 7Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasm Metastasis 6Melanoma 6Carcinoma, Ovarian Epithelial 6Thymoma 5Pleural Effusion, Malignant 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pain 4Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3

Interventions

Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Kidney Neoplasms × Thoracic × Clear all
NCT00471432 2023-08-04

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
40 enrolled
BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡